Correction

Author Correction: Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibition

Kai-long Jiang1,2,3,4,5, Chang-mei Liu3,6, Li-tong Nie3, Hai-ni Jiang2,7, Lei Xu2,3, Kun-zhi Zhang3,8, Li-xia Fan3, An-hui Gao3, Lu-lin Lin1, Xiang-yu Wang5, Min-jia Tan3, Qi-qing Zhang1, Yu-bo Zhou2,3,4, Jia Li2,3,4,7,9
1 Institute of Biomedical Engineering, The Second Clinical Medical College, Jinan University (Shenzhen People’s Hospital), Shenzhen 518020, China
2 Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China
3 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
4 University of Chinese Academy of Sciences, Beijing 100049, China
5 The First Affiliated Hospital, Jinan University, Guangzhou 510632, China
6 School of Pharmaceutical Science, Jiangnan University, Wuxi 214122, China
7 School of Pharmacy, Zunyi Medical University, Zunyi 563006, China
8 Zhejiang Center for Medical Device Evaluation, Zhejiang Medical Products Administration, Hangzhou 311121, China
9 Shanghai Tech University, Shanghai 201210, China
Correspondence to: Qi-qing Zhang: zhang.qiqing@szhospital.com, Yu-bo Zhou: ybzhou@simm.ac.cn, Jia Li: jli@simm.ac.cn,
DOI: 10.1038/s41401-023-01132-4
Advance online: 4 August 2023

Article Options

Download Citation

Cited times in Scopus